RO4602522: Clinical Trials

1 trial of RO4602522, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow RO4602522: new trials by email Literature Review of RO4602522 trials Research Report on RO4602522

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of RO4602522 in Participants With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy
RO4602522, Placebo, Donepezil - Alzheimer's Disease
Phase 2CompletedHoffmann-La Roche5422012-10-242017-05-30

Conditions studied

Alzheimer Disease (1)

Sponsors

Hoffmann-La Roche (1)

Countries

Australia (1)  ·  Canada (1)  ·  Czechia (1)  ·  France (1)  ·  Germany (1)  ·  Italy (1)  ·  Poland (1)  ·  South Korea (1)  ·  Spain (1)  ·  Sweden (1)  ·  United Kingdom (1)  ·  United States (1)

Results publications

PMID 28550255